Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations

Most children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have mild or minimal disease, with a small proportion developing severe disease or multisystem inflammatory syndrome in children (MIS-C). Complement-mediated thrombotic microangiopathy (TMA) has been associated...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Diorio, Caroline, McNerney, Kevin O., Lambert, Michele, Paessler, Michele, Anderson, Elizabeth M., Henrickson, Sarah E., Chase, Julie, Liebling, Emily J., Burudpakdee, Chakkapong, Lee, Jessica H., Balamuth, Frances B., Blatz, Allison M., Chiotos, Kathleen, Fitzgerald, Julie C., Giglia, Therese M., Gollomp, Kandace, Odom John, Audrey R., Jasen, Cristina, Leng, Tomas, Petrosa, Whitney, Vella, Laura A., Witmer, Char, Sullivan, Kathleen E., Laskin, Benjamin L., Hensley, Scott E., Bassiri, Hamid, Behrens, Edward M., Teachey, David T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2020
Soggetti:
Vascular Biology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724906/
https://ncbi.nlm.nih.gov/pubmed/33290544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003471
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi